Tracking JAKs in spondyloarthritis: rationale and expectations

Ann Rheum Dis. 2017 Aug;76(8):1325-1326. doi: 10.1136/annrheumdis-2016-210886. Epub 2017 Mar 17.

Authors

Corinne Miceli-Richard^{1

2}, Maxime Dougados^{1

2

3}

Affiliations

¹ Department of Rheumatology-Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France.
² Immunoregulation Unit, Unité Mixte AP-HP/Institut Pasteur, Institut Pasteur, Paris, France.
³ INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France.

PMID: 28314752
DOI: 10.1136/annrheumdis-2016-210886

No abstract available

Keywords: Chemokines; Cytokines; DMARDs (biologic); Spondyloarthritis; Treatment.

Publication types

Editorial
Comment

MeSH terms

Humans
Motivation
Piperidines
Pyrimidines
Pyrroles
Spondylarthritis*
Spondylitis, Ankylosing*

Substances

Piperidines
Pyrimidines
Pyrroles
tofacitinib